Replies to post #76464 on Biotech Values

[DewDiligence]

ANDS IDIX – Today’s negative news on ANA598 makes IDIX’s IDX375 program somewhat more valuable.

[tony111]

combine it with Rib you are going to have more patients dropping out from rash. The management was dumb not to raise money when they had a chance.